BIOMAT Database Logo BIOMAT Database Logo

[Treatment of intestinal amebiasis by a new contact amebicide]. 1968

C Pedoya, and C Laverdant, and P Boisselier

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004404 Dysentery, Amebic DYSENTERY caused by intestinal amebic infection, chiefly with ENTAMOEBA HISTOLYTICA. This condition may be associated with amebic infection of the LIVER and other distant sites. Amebiasis, Intestinal,Amebic Dysentery,Colitis, Amebic,Entamoebiasis, Intestinal,Intestinal Amebiasis,Amoebiasis, Intestinal,Amoebic Colitis,Amoebic Dysentery,Intestinal Amoebiasis,Intestinal Entamoeba histolytica Infection,Amebiases, Intestinal,Amebic Colitides,Amebic Colitis,Amebic Dysenteries,Amoebiases, Intestinal,Amoebic Colitides,Amoebic Dysenteries,Colitides, Amebic,Colitides, Amoebic,Colitis, Amoebic,Dysenteries, Amebic,Dysenteries, Amoebic,Dysentery, Amoebic,Entamoebiases, Intestinal,Intestinal Amebiases,Intestinal Amoebiases,Intestinal Entamoebiases,Intestinal Entamoebiasis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000563 Amebicides Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. Amoebicides

Related Publications

C Pedoya, and C Laverdant, and P Boisselier
[Treatment of intestinal amebiasis in man with a new amebicide: Win 5047; preliminary report].
January 1957, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
C Pedoya, and C Laverdant, and P Boisselier
[Treatment of intestinal amebiasis--preliminary results of a trial with a new drug, Bayer 2456 (amebicide)].
September 1965, Revista brasileira de medicina,
C Pedoya, and C Laverdant, and P Boisselier
Biallylamicol, a new amebicide: chemotherapeutic studies in intestinal and hepatic amebiasis in animals.
August 1955, Antibiotics & chemotherapy (Northfield, Ill.),
C Pedoya, and C Laverdant, and P Boisselier
[Metronidazole, a diffusible amebicide and contact amebicide, in the treatment of amebiasis. Demonstration of the presence of its main metabolite in feces].
January 1968, Medecine tropicale : revue du Corps de sante colonial,
C Pedoya, and C Laverdant, and P Boisselier
[An antibiotic amebicide, fumagillin; oral and atoxic therapy of intestinal amebiasis].
November 1953, El Dia medico,
C Pedoya, and C Laverdant, and P Boisselier
[Clinical study of a new contact amebicide: entamide furoate].
January 1963, La Presse medicale,
C Pedoya, and C Laverdant, and P Boisselier
[Preliminary note on the action of Win-Am-13146 (Teclosine) in intestinal amebiasis. Clinico-therapeutic trial of a new amebicide].
December 1962, Hospital (Rio de Janeiro, Brazil),
C Pedoya, and C Laverdant, and P Boisselier
Polybenzarsol; a new amebicide.
August 1958, Antibiotics & chemotherapy (Northfield, Ill.),
C Pedoya, and C Laverdant, and P Boisselier
[Treatment of intestinal amebiasis by oral emetine].
February 1951, Maroc medical,
C Pedoya, and C Laverdant, and P Boisselier
[The treatment of intestinal amebiasis by glaucarubin].
August 1959, La Presse medicale,
Copied contents to your clipboard!